Where & When

Saturday, April 12, 2025
Detroit Marriott
200 W. Big Beaver Road
Troy, MI 48084

Registration

Don’t delay! Registration deadline is Thursday, April 10, 2025.

Register Now

Cost to attend is $125 for physicians and pharmacists; $50 for mid-level providers, retired physicians and other allied health providers; $25 for nurses and CTO staff. The conference is $20 for fellows, residents, and medical students, which is refundable upon attendance.

Target Audience

This program is geared towards general physicians, surgeons, fellows, residents, students, pathologists, radiation oncologists, pharmacists, physician assistants, nurse practitioners and nurses in the field of hematology and oncology.

Educational Objectives

Upon completion of this programs, the participant will:

  1. Integrate diagnostic and therapeutic strategies used in the multimodality treatment of patients with breast cancer.
  2. Specify the use of new agents, both cytotoxic and biologic, and their uses in treating breast cancer.
  3. Identify the latest research findings in all areas of breast cancers and how the updated research could impact future decision making in the diagnosis and treatment of these cancers.

Accreditation

This activity has been approved for AMA PRA Category 1 Credit™ Provided by Wayne State University School of Medicine and Karmanos Cancer Institute.

Agenda

  • 8:00 - 8:50: Registration | Breakfast
  • 8:50 - 9:00: Opening Remarks
    Lydia Choi, M.D. and Hadeel Assad, M.D.

    9:00 - 9:30: Updates onHER2+ Breast Cancer
    Jailan Elayoubi, M.D.
    Barbara Ann Karmanos Cancer Institute

    9:30 - 10:00: Updates in Breast Reconstruction
    Guillermina Nava, M.D.
    Barbara Ann Karmanos Cancer Institute

    10:00 - 11:00: Overview of Anthracycline Use in Breast Cancer
    Sarah Hurvitz, M.D., FACP
    Fred Hutchinson Cancer Center, Seattle, Washington

    11:00 - 11:45: Case Presentations and Discussion Panel

    Moderator: Lubina Arjyal, M.D., Barbara Ann Karmanos Cancer Institute

    11:45-12:30: Lunch

    12:30-1:30: DCIS
    Kelly C. Hewitt, M.D., FACS (she/her)
    Huntsman Cancer Institute at The University of Utah
    Salt Lake City, Utah

    1:30-2:00: Updates in ER+ and TNBC
    Lawrence Flaherty, M.D.
    Barbara Ann Karmanos Cancer Institute

    2:00-2:30: Updates in Breast Cancer Radiotherapy
    Brian Yeh, M.D., Ph.D..
    Barbara Ann Karmanos Cancer Institute

    2:30-3:00: Women's Wellness Clinic: Survivorship, High-Risk Screening
    Amy Legghio, MSN, CNP, OCN
    Barbara Ann Karmanos Cancer Institute

    3:00: Closing Remarks

    More Information

    For any additional questions, please contact Pamela Sydorchuk, symposium coordinator, at symposium@karmanos.org or call 313-576-8746.

    The Latest From Karmanos Cancer Institute

    News

    YesRx, Karmanos and McLaren Partner to Help Michigan Cancer Patients

    Michigan residents impacted by cancer and the costs of cancer medication now have a new resource to help address the financial burden and the wast...

    Read More

    IN THE NEWS: A Spoonful of Innovation: Karmanos Pioneers At-home Liver Cancer Treatment

    Becker’s Hospital Review Boris Pasche, M.D., Ph.D., FACP , president and CEO at Karmanos, answered some questions about the new FDA-approved Thera...

    Read More

    18 Karmanos Physicians on Castle Connolly 2025 Top Doctors List

    Castle Connolly’s 2025 Top Doctors list has been announced, with 18 Barbara Ann Karmanos Cancer Institute physicians listed. There are about 1 mil...

    Read More
    News

    WDET | Doctor Says HPV Vaccine and Routine Screenings Aid Against Cervical Cancer

    Listen Now

    WWJ | World Cancer Day

    Listen Now

    WWJ | Ribbon Cutting Held for New Karmanos Cancer Center in Dearborn That Strives to Improve Access to Treatment, Clinical Trials

    Listen Now